Last reviewed · How we verify
Hepatic encephalopathy
Approved treatments
- xifaxan · Children's Hospital Los Angeles
- Xifaxan · Bausch Health
- Cephulac · Sanwa Kagaku Kenkyusho Co., Ltd.
- Cortisporin · Pfizer
- Rifaximine · Ain Shams University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hepatic encephalopathy patent landscape — cliff calendar, originator estates, attackable patents
- Hepatic encephalopathy treatment landscape brief
- Hepatic encephalopathy treatment updates RSS
Frequently asked questions about Hepatic encephalopathy
What drugs treat Hepatic encephalopathy?
Tracked treatments include xifaxan, Xifaxan, Cephulac, Cortisporin, Rifaximine.
What is the treatment for Hepatic encephalopathy?
Standard treatment for Hepatic encephalopathy includes xifaxan, Xifaxan, Cephulac, Cortisporin, Rifaximine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hepatic encephalopathy patent cliff · Hepatic encephalopathy CI report
- Treatment: xifaxan · Children's Hospital Los Angeles
- Treatment: Xifaxan · Bausch Health
- Treatment: Cephulac · Sanwa Kagaku Kenkyusho Co., Ltd.
- Treatment: Cortisporin · Pfizer
- Treatment: Rifaximine · Ain Shams University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing